Spanish Luxury Stock News

BME:TRE
BME:TREEnergy Services

A Look At Técnicas Reunidas (BME:TRE) Valuation After New Carbon Capture Consortium With Ferrovial

Técnicas Reunidas (BME:TRE) is in focus after forming a consortium with Ferrovial to develop carbon capture technology. This move puts its low carbon segment and energy transition exposure under the spotlight for investors. See our latest analysis for Técnicas Reunidas. The consortium news arrives after a strong run, with a 9.39% 1 month share price return and a 22.79% year to date share price return. The 1 year total shareholder return is very large, indicating that momentum has been...
BME:CLNX
BME:CLNXTelecom

Cellnex Telecom (BME:CLNX) Valuation Check As Precision Positioning Deal Targets Automation Growth

Cellnex Telecom (BME:CLNX) is back in focus after announcing a collaboration with Point One Navigation to roll out centimeter level positioning services across six European markets using its neutral host tower network. See our latest analysis for Cellnex Telecom. The new positioning partnership comes after a sharp 19.3% 30 day share price return and a 12.9% year to date share price return. However, the 1 year total shareholder return of 7.4% and 5 year total shareholder return of 21.2% show...
BME:ELE
BME:ELEElectric Utilities

Endesa (BME:ELE) Margin Strength To 10.3% Challenges Bearish Profit Compression Narrative

Endesa (BME:ELE) has wrapped up FY 2025 with fourth quarter revenue of €5.7b and basic EPS of €0.47, while trailing twelve month revenue sits at €21.4b and EPS at €2.11. This sets a clear benchmark for how the year closed. Over the past few quarters, revenue has ranged from €4.9b to €5.8b per quarter and quarterly EPS has moved between €0.43 and €0.63, giving investors a consistent read on how top line and per share earnings have flowed through the year. With net profit margin at 10.3% and...
BME:MVC
BME:MVCReal Estate

Metrovacesa (BME:MVC) Q3 Net Margin At 4.2% Challenges Premium P/E Narrative

Metrovacesa (BME:MVC) has posted its Q3 2025 numbers with total revenue of €287.97 million and basic EPS of €0.24, alongside trailing 12 month EPS of €0.18 on revenue of €631.51 million. These figures are set against earnings growth of 56.6% over the past year. The company has seen quarterly revenue move from €211.36 million with EPS of €0.04 in late 2024 to €287.97 million with EPS of €0.24 in 2025, while its reported net margin has shifted from 2.6% to 4.2%. Together, these changes frame...
BME:LDA
BME:LDAInsurance

Línea Directa (BME:LDA) Margin Rebound Challenges Cautious Earnings Narratives

Línea Directa Aseguradora Compañía de Seguros y Reaseguros (BME:LDA) has wrapped up FY 2025 with fourth quarter revenue of €284.5 million and net income of €26.0 million, capping a twelve month run that produced €1.2b in revenue and €127.5 million in net income. The company has seen trailing twelve month revenue move from €1.0b at the end of 2024 to €1.2b by the close of 2025, while net income over the same window went from €64.2 million to €127.5 million. This came alongside quarterly EPS...
BME:ENO
BME:ENOConstruction

A Look At Elecnor (BME:ENO) Valuation After New Statkraft Grid Stability Contracts

Event overview and why it matters for Elecnor Elecnor (BME:ENO) has secured two additional contracts from Statkraft for synchronous condenser projects in Ireland, doubling its involvement in the grid stability programme and reinforcing its role in renewable integration and fossil fuel reduction efforts. See our latest analysis for Elecnor. At a share price of €29.25, Elecnor has a 1 month share price return of 11.22% and a year to date share price return of 19.63%, while its 1 year total...
BME:GRE
BME:GRERenewable Energy

Assessing Grenergy Renovables (BME:GRE) Valuation After Strong 2025 Results And Major Chile Project Financing

Grenergy Renovables (BME:GRE) is back in focus after reporting full year 2025 results with sales of €1,069.9 million and net income of €87 million, along with a new $355 million non recourse financing package in Chile. See our latest analysis for Grenergy Renovables. The latest full year results and the $355 million Chile financing appear to have caught investors’ attention, with a 61.3% 90 day share price return and a very large 1 year total shareholder return suggesting strong momentum...
BME:ALM
BME:ALMPharmaceuticals

Almirall (BME:ALM) EPS Rebound Tests Bullish Growth Narratives Despite Rich 59.8x P/E

Almirall FY 2025: Earnings Momentum Meets Rich Valuation Debate Almirall (BME:ALM) has capped FY 2025 with fourth quarter revenue of €310.6 million and net income of €7.1 million, while its trailing 12 month EPS stands at €0.22 on net income of €46.2 million. This sets a clear earnings benchmark for investors watching its recent turnaround. The company has seen trailing 12 month revenue move from €990.6 million at the end of 2024 to €1.14 billion by the close of 2025, with trailing EPS...
BME:ITX
BME:ITXSpecialty Retail

Assessing Inditex (BME:ITX) Valuation After Recent Share Price Strength

Assessing Industria de Diseño Textil after recent share performance Industria de Diseño Textil (BME:ITX) has attracted fresh attention after a steady run in its share price, with returns of 4.6% over the past month and 19.8% over the past 3 months. For investors, that recent performance sits alongside annual revenue of €39.4b and net income of €6.0b. These figures help frame expectations around what you might reasonably pay for exposure to the Zara and related brands. See our latest analysis...
BME:IBE
BME:IBEElectric Utilities

Is It Too Late To Consider Iberdrola (BME:IBE) After A 49% One Year Rally?

If you are looking at Iberdrola and wondering whether the recent share price levels still make sense, focusing on value rather than just the story can help you frame that decision. The stock last closed at €20.05, with a 7 day return of a 0.2% decline, a 30 day return of 9.2%, a year to date return of 7.6% and a 1 year return of 49.1%, while the 3 year and 5 year returns sit at 105.1% and 130.1% respectively. These moves sit against a backdrop of ongoing interest in European utilities and...
BME:ELE
BME:ELEElectric Utilities

Endesa (BME:ELE) Valuation Check After Full Year 2025 Earnings Lift Sales And Net Income

Full year 2025 earnings set the context Endesa (BME:ELE) has drawn fresh attention after reporting full year 2025 earnings, with sales of €21,424 million and net income of €2,198 million, compared with €21,307 million and €1,888 million a year earlier. See our latest analysis for Endesa. The full year 2025 report appears to have been a key catalyst for Endesa, with a 1 day share price return of 1.72% and a 30 day share price return of 5.54% pointing to building momentum on the back of higher...
BME:GRE
BME:GRERenewable Energy

Is US$355m Central Oasis Hybrid Financing Altering The Investment Case For Grenergy Renovables (BME:GRE)?

In February 2026, Grenergy Renovables announced it had secured a US$355,000,000 non-recourse senior financing package from BNP Paribas, Santander and Rabobank to refinance and expand several Central Oasis solar-plus-storage projects in Chile totaling 398 MW of solar capacity and 1.4 GWh of storage. This agreement, fully backed by long-term power purchase agreements and complemented by energy sales through its GR Power retail arm, strengthens Grenergy’s position in Chile’s hybrid renewable...
BME:CABK
BME:CABKBanks

CaixaBank (BME:CABK) FY 2025 Margin Strength Reinforces Bullish Profitability Narratives

CaixaBank (BME:CABK) has just posted its FY 2025 numbers with fourth quarter revenue of €3.9b and basic EPS of €0.21, framing a year in which trailing twelve month revenue reached €15.3b and EPS came in at €0.83. Over recent periods, revenue has moved from €14.8b on a trailing basis at the end of 2024 to €15.3b by the end of 2025, while trailing EPS increased from €0.76 to €0.83. This sets the backdrop for a story focused on earnings momentum and profitability. With a reported trailing net...
BME:CABK
BME:CABKBanks

Assessing CaixaBank (BME:CABK) Valuation After Planned Amortization Of Convertible Preferred Securities

CaixaBank (BME:CABK) has drawn fresh attention after announcing the amortization of convertible preferred securities issued in March 2018. This capital structure move is scheduled for March and could influence how investors view its financial flexibility. See our latest analysis for CaixaBank. At a share price of €10.7, CaixaBank has seen a 15.63% 90 day share price return and a very large 5 year total shareholder return, which suggests that momentum has been strong rather than fading...
BME:PUIG
BME:PUIGPersonal Products

Puig Brands BME PUIG Margin Resilience Challenges Bearish Narratives In FY 2025 First Half

Puig Brands (BME:PUIG) prints higher revenue and EPS into FY 2025 Puig Brands (BME:PUIG) opened FY 2025 with first half revenue of about €2.3b and basic EPS of €0.49, setting the tone for another year where the income statement is front and center for investors watching the fragrance and beauty group. The company has seen revenue move from €2.17b in the first half of 2024 to €2.62b in the second half of 2024 and then to €2.30b in the first half of 2025, while basic EPS shifted from €0.27 to...
BME:SAB
BME:SABBanks

Assessing Banco Sabadell (BME:SAB) Valuation After CEO Exit And Weaker Earnings

CEO transition and softer earnings put Banco de Sabadell in focus Banco de Sabadell (BME:SAB) is in the spotlight after its CEO, César González-Bueno, agreed with the board to step down, alongside quarterly and full year results showing year-over-year net income declines. See our latest analysis for Banco de Sabadell. At a share price of €3.196, Banco de Sabadell has seen mixed share price momentum recently, with a 1 day share price return of 0.63% but a year to date share price return...
BME:COXG
BME:COXGRenewable Energy

3 European Stocks Estimated To Be Up To 47.9% Below Intrinsic Value

As European markets navigate volatility and digest global economic data, the pan-European STOXX Europe 600 Index recently reached a new high before settling with a modest gain. Amid these fluctuating conditions, identifying undervalued stocks can be crucial for investors seeking potential opportunities; such stocks may offer value by trading below their intrinsic worth despite broader market challenges.
BME:FDR
BME:FDRMachinery

Assessing Fluidra (BME:FDR) Valuation As Investor Interest Returns To The Stock

Why Fluidra Stock Is Back on Investors’ Radar Fluidra (BME:FDR) has caught investor attention again after a period of mixed short term returns, with the share price slightly lower over the past week but positive over the month and past 3 months. See our latest analysis for Fluidra. While the 1 day share price return of Fluidra shows a small decline, the 90 day share price return of 13.02% and 1 year total shareholder return of 11.86% suggest that momentum has been building over a longer...
BME:PHM
BME:PHMBiotechs

European Stocks That May Be Trading Below Their Estimated Value In February 2026

As European markets experience volatility amid concerns about AI disruption and digest strong U.S. job data, the pan-European STOXX Europe 600 Index has reached new highs but remains largely unchanged. In this environment, identifying stocks that may be trading below their estimated value can offer potential opportunities for investors looking to capitalize on market inefficiencies.
BME:LIB
BME:LIBReal Estate

European Penny Stocks Spotlight: Libertas 7 And 2 Other Noteworthy Picks

European markets have experienced volatility recently, with the pan-European STOXX Europe 600 Index hitting a new high but ultimately ending the week with only a slight gain. In such fluctuating conditions, investors may find opportunities in lesser-known segments like penny stocks. Though often seen as remnants of past eras, penny stocks can offer affordability and growth potential when backed by strong financials.
BME:GRF
BME:GRFBiotechs

Evaluating Whether Grifols (BME:GRF) Is Undervalued After Recent Share Price Stability

Grifols stock overview after recent moves Grifols (BME:GRF) has drawn fresh attention after its recent share price moves, with investors weighing solid revenue and net income figures against mixed return trends over the past few years. See our latest analysis for Grifols. Recent trading has been relatively steady, with a 3.45% 90 day share price return and a 20.65% 1 year total shareholder return contrasting with weaker multi year total shareholder returns. This suggests momentum has picked...
BME:BBVA
BME:BBVABanks

Is There Still Value In BBVA (BME:BBVA) After Its Strong Multi Year Rally?

If you are wondering whether Banco Bilbao Vizcaya Argentaria is still good value after its recent run, this article walks through what the current share price might be implying about the bank. The stock recently pulled back, with a 5.3% decline over the last 7 days and an 8.8% decline over the last 30 days, after very strong returns of 66.1% over 1 year and roughly 7x over 5 years. Recent coverage has focused on BBVA's position among European banks and how investor sentiment has shifted...